← Back to headlines
Zealand Pharma Reports 17% Weight Loss in Late-Stage GLP-1 Trial with Boehringer
Zealand Pharma announced that its GLP-1 drug, developed in collaboration with Boehringer Ingelheim, achieved an average of 17% weight loss in participants during a late-stage clinical trial.
28 Apr, 16:03 — 28 Apr, 16:03
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
EV Charging Stations Become Essential Service in Tourism and Hospitality
10m ago
Sentuo Refinery Receives 1 Million Barrels of Jubilee Crude for Local Processing
10m ago
Ogyre Launches 'Ocean Challenge 2026' to Collect 40,000 kg of Marine Waste
11m ago